Ninoxan (Nitrous Oxide, Oxygen)

Nitrous oxide, the active ingredient in Ninoxan, is a inhalational anesthetic presented as a gas for inhalation use. It provides analgesia, sedation and can be used to induce general anesthesia in surgical and procedural settings. GNH USA supplies Ninoxan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Ninoxan acts on the central nervous system to provide pain relief and sedation in procedural and surgical contexts.

Analgesia: delivers rapid pain relief during minor surgical or diagnostic procedures. Sedation: produces conscious sedation for endoscopic, dental or imaging examinations. Anesthesia: induces and maintains general anesthesia for operative interventions.

Adverse reactions may occur with inhalation of nitrous oxide‑oxygen mixtures.

Common Side Effects: - Nausea or vomiting - Dizziness or light‑headedness - Headache - Increased salivation or mild euphoria

Serious or Rare Side Effects: - Respiratory depression or hypoxia - Cardiovascular instability (hypotension, arrhythmia) - Malignant hyperthermia - Loss of consciousness or seizures

Safe use of Ninoxan requires careful patient assessment and monitoring.

Assess respiratory function: ensure adequate ventilation before and during administration. Monitor cardiovascular status: watch for hypotension or arrhythmias. Avoid use in severe COPD or obstructive airway disease. Use with caution in pregnancy: potential fetal effects are unknown. Store at ambient temperature: keep cylinders upright in original packaging, protect from heat and direct sunlight.

Nitrous oxide can interact with other central nervous system depressants and certain cardiovascular agents.

Major Interactions (Avoid): - Concurrent use with other CNS depressants: risk of profound sedation. - Combination with volatile anesthetics: additive respiratory depression. - Use with MAO inhibitors: unpredictable hemodynamic response.

Moderate Interactions (Monitor Closely): - Co‑administration with opioid analgesics: enhanced respiratory effects. - Use with benzodiazepines: increased sedation. - Concomitant nitroglycerin therapy: possible hypotension.